Cheryl L. Newman

Infectious Disease

1120 15th St
Augusta, GA 30912

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy.

Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy.

Journal: AIDS (London, England)

Published: October 15, 2021

Showing 1-1 of 1

Last Updated: 09/26/2026